Filter by: patients
Home > Community Treatment Reports and Side Effects > Medroxyprogesterone Acetate Treatment Report
What is Medroxyprogesterone Acetate?

Medroxyprogesterone acetate is a contraceptive used for endometrial carcinoma or renal carcinoma; secondary amenorrhea or abnormal uterine bleeding due to hormonal imbalance; reduction of endometrial hyperplasia in nonhysterectomized postmenopausal women receiving conjugated estrogens.

Reported Purpose & Efficacy

Reasons and Efficacy
Purpose # of patients
# of patients with evaluations Efficacy
Major
Moderate
Slight
None
Can’t tell
PCOS (Polycystic Ovary Syndrome) 26 3 Efficacy_major Efficacy_none Efficacy_cant_tell
Other 21 7 Efficacy_major
Birth control 19 9 Efficacy_major Efficacy_cant_tell
Absence of menstruation (amenorrhea) 4 1 Efficacy_cant_tell
Support hormone balance 3 0
HRT 3 1 Efficacy_moderate

See all 67 patients currently taking Medroxyprogesterone Acetate

Mouse over the table for more information

Reported Side Effects

Side effects as an overall problem

Severe
 6
Moderate
 6
Mild
 4
None
 16

Commonly reported side effects, conditions, and hospitalizations associated with Medroxyprogesterone Acetate

Vaginal dryness 2
Breakthrough intermenstrual bleeding 2
Absence of menstruation (amenorrhea) 2
Weight gain 2
Depressed mood 2
Breast tenderness 1
See all 16 reported side effects ▼ See top 6 reported side effects ▲

Reported Dosages

Frequently reported dosages based on patients currently taking Medroxyprogesterone Acetate. See all 29 dosages ►

  1mg as needed 150mg as needed 400mg/mL as needed 10 mg every 3 months 150 mg every 3 months 2.5 mg daily 100 mg monthly 400 mg every 3 months 5 mg daily 20 mg daily
  2 Number of Patients: 2 3 Number of Patients: 3 4 Number of Patients: 4 2 Number of Patients: 2 4 Number of Patients: 4 10 Number of Patients: 10 6 Number of Patients: 6 11 Number of Patients: 11 2 Number of Patients: 2 3 Number of Patients: 3  

Reported Stop Reasons

Why Patients Stopped Taking Medroxyprogesterone Acetate (multiple reasons could be selected)
Reason # Patients Percentage of patients
Side effects too severe 18   Side effects too severe: 37%
Doctor's advice 17   Doctor's advice: 35%
Course of treatment ended 13   Course of treatment ended: 27%
Other 10   Other: 20%
Personal research 4   Personal research: 8%
Did not seem to work 4   Did not seem to work: 8%
Expense 2   Expense: 4%

See all 49 patients who’ve stopped taking Medroxyprogesterone Acetate

Reported Duration See details about how long patients take this treatment ▼

Currently Taking Medroxyprogesterone Acetate

A bar graph

0-1 month 1-3 months 3-6 months 6 months-1year 1-2 years 2 years or more
0

Stopped Taking Medroxyprogesterone Acetate

A bar graph

0-1 month 1-3 months 3-6 months 6 months-1year 1-2 years 2 years or more

Reported Adherence, Burden & Cost See details from patient evaluations ▼

Adherence

Taking treatment as prescribed

Adherence of Medroxyprogesterone Acetate

Always
 29 91%
Usually
 1 3%
Sometimes
 1 3%
Never
 1 3%

Burden

Difficulty being on treatment

Burden of Medroxyprogesterone Acetate

Very
 1 3%
Somewhat
 4 13%
A little
 5 16%
Not at all
 22 69%

Cost

Paid out of pocket

Cost of Medroxyprogesterone Acetate

$200+
 0 0%
$100-199
 0 0%
$50-99
 1 6%
$25-49
 2 11%
< $25
 15 83%

See more information, including instructions, precautions, side effects, and interactions.

Report created on May 24, 2012.